The world market is currently valued at $7.25bn and revenues are forecasts to rise to over $14bn in 2009. Do you know what the drivers and restraints of the market are? This report not only reveals these, but also details what stratergies can be used to maxmise profits from the drivers and restraints? Ensure your organisation is successful in this market by reserving your copy of it’s’s report today.
According to the findings of the new 170+page report, it’s reveals that Glaucoma therapies are set to dominate the market over the forecast period (2002-2009), accounting for almost 40% of market revenues by 2009. Indeed, 2004 saw the first blockbuster drug of the market, used to treat glaucoma.
Find out who are the major companies involved in the ophthalmic world market today and in the future. And what R&D opportunities exist for ‘new-comers’
In the process of providing a thorough evaluation of the market, the it’s Ophthalmics report focuses on the major therapeutic areas of the market:
Dry Eye Syndrome
Do you know what the market values of these major therapeutic areas of the ophthalmic world market are?
The report provides in-depth market analysis upon these areas, and extensively identifies both prescription and OTC ophthalmic drugs by disease and product type. The study also assess’s the challenges faced by ophthalmic companies, and what exciting market opportunites exist in this up- and-coming therapeutic area.
Why You Must Buy This Report?
This report features over 50 tables, 30 graphs and charts, news, insights, the latest developments and an in depth survey of the ophthalmics market with up-to-date analysis. This report is a vital addition to gaining an understanding of this highly profitable market sector and will give your company ‘the edge’ on your competitiors. You can not afford to be without this latest report from it’s.
For more information, kindly visit :